Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4475
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ionis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Ionis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ionis Pharmaceuticals, Inc. (Ionis or “the company”) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. The company primarily operates in the US. Ionis is headquartered in Carlsbad, California, the US.

Scope

- Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Ionis Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ionis Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Ionis Pharmaceuticals, Inc.: Company Overview 9
Ionis Pharmaceuticals, Inc.: Overview and Key Facts 9
Ionis Pharmaceuticals, Inc.: Overview 9
Ionis Pharmaceuticals, Inc.: Key Facts 9
Ionis Pharmaceuticals, Inc.: Key Employees 11
Ionis Pharmaceuticals, Inc.: Key Employee Biographies 12
Ionis Pharmaceuticals, Inc.: Major Products and Services 15
Ionis Pharmaceuticals, Inc.: Company History 16
Ionis Pharmaceuticals, Inc.: Management Statement 21
Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries 24
Ionis Pharmaceuticals, Inc.: Key Competitors 25
Ionis Pharmaceuticals, Inc.: Company Analysis 26
Ionis Pharmaceuticals, Inc.: Business Description 26
Ionis Pharmaceuticals, Inc.: SWOT Analysis 27
Ionis Pharmaceuticals, Inc.: SWOT Overview 27
Ionis Pharmaceuticals, Inc.: Strengths 27
Ionis Pharmaceuticals, Inc.: Weaknesses 28
Ionis Pharmaceuticals, Inc.: Opportunities 28
Ionis Pharmaceuticals, Inc.: Threats 29
Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity 31
Ionis Pharmaceuticals, Inc.: Financial Deals Overview 31
Ionis Pharmaceuticals, Inc.: Targets and Partners 33
Ionis Pharmaceuticals, Inc.: Top Deals 2014 – 2018YTD* 35
Ionis Pharmaceuticals, Inc.: Advisors 36
Ionis Pharmaceuticals, Inc.: Top Legal Advisors 36
Ionis Pharmaceuticals, Inc.: Top Financial Advisors 36
Ionis Pharmaceuticals, Inc.: Corporate Venturing 37
Ionis Pharmaceuticals, Inc.: Capital Raising 38
Ionis Pharmaceuticals, Inc.: Partnership 39
Ionis Pharmaceuticals, Inc.: Divestments 40
Ionis Pharmaceuticals, Inc.: Private Equity and Ownership 41
Ionis Pharmaceuticals, Inc.: Recent Developments 42
Ionis Pharmaceuticals, Inc.: News and Events Summary 42
Ionis Pharmaceuticals, Inc.: Corporate Governance 45
Ionis Pharmaceuticals, Inc.: Financial Performance 46
Ionis Pharmaceuticals, Inc.: Market Developments 46
Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events 48
Ionis Pharmaceuticals, Inc.: Strategy and Operations 49
Appendix 50
Contact Us 50
Methodology 50
About MarketLine 51

List of Tables
Table 1: Ionis Pharmaceuticals, Inc.: Key Facts
Table 2: Ionis Pharmaceuticals, Inc.: Key Employees
Table 3: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 4: Ionis Pharmaceuticals, Inc.: Key Competitors
Table 5: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Ionis Pharmaceuticals, Inc.: Targets and Partners
Table 8: Ionis Pharmaceuticals, Inc.: Top Deals 2014 - 2018YTD*
Table 9: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 16: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 17: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 18: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014 - YTD*2018)
Table 19: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 20: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 21: Ionis Pharmaceuticals, Inc.: News and Events Summary
Table 22: Ionis Pharmaceuticals, Inc.: Corporate Governance
Table 23: Ionis Pharmaceuticals, Inc.: Financial Performance
Table 24: Ionis Pharmaceuticals, Inc.: Market Developments
Table 25: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 26: Ionis Pharmaceuticals, Inc.: Strategy and Operations

List of Figures
Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 4: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 5: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014 - YTD*2018)
Figure 11: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Advaxis Inc (ADXS):企業の財務・戦略的SWOT分析
    Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Jacobs Engineering Group Inc (JEC)-エネルギー分野:企業M&A・提携分析
    Summary Jacobs Engineering Group Inc. (Jacobs) is a provider of technical professional services. The company offers a diverse range of technical, professional, and construction services to industrial, commercial, and governmental customers across the globe. Its service portfolio includes project; pr …
  • Endo International Plc (ENDP)-製薬・医療分野:企業M&A・提携分析
    Summary Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, …
  • Recipharm AB (RECI B):医療機器:M&Aディール及び事業提携情報
    Summary Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, and development and technology services. The organization's manufacturing segment provides contract manufacturing of pharmaceuticals such as semi-solids, and oral liquids, soli …
  • Heska Corp (HSKA):企業の財務・戦略的SWOT分析
    Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Desjardins Financial Security Life Assurance Company:企業の戦略・SWOT・財務情報
    Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report Summary Desjardins Financial Security Life Assurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Exillon Energy Plc (EXI):企業の財務・戦略的SWOT分析
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Tidewater Inc (TDW):企業の財務・戦略的SWOT分析
    Summary Tidewater Inc (Tidewater) is an an petroleum service company that offers offshore supply vessels and marine support services. The company's services include transport and supply of offshore material; anchor handling, towing and positioning; construction support; well stimulation, FPSO suppor …
  • Singapore Technologies Electronics Ltd:戦略・SWOT・企業財務分析
    Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Qualcomm Incorporated (QCOM):企業の財務・戦略的SWOT分析
    Qualcomm Incorporated (QCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Mobile Telesystems:企業の戦略・SWOT・財務情報
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Exco Resources Inc (XCOOQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, and production of onshore natural gas and oil assets. It provides services such as portfolio re …
  • Bank of Communications Ltd (601328):企業の財務・戦略的SWOT分析
    Bank of Communications Ltd (601328) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Feintool International Holding AG (FTON):企業の財務・戦略的SWOT分析
    Feintool International Holding AG (FTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Onconova Therapeutics Inc (ONTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Onconova Therapeutics Inc (Onconova) is a biopharmaceutical company that discovers and develops small molecule drug candidates for the treatment of cancer. The company’s drug candidates include rigosertib, briciclib and recilisib. It develops drug candidates that target cancer and protect he …
  • Strategic Oil & Gas Ltd (SOG):企業の財務・戦略的SWOT分析
    Summary Strategic Oil & Gas Ltd (Strategic Oil & Gas) is an upstream oil and gas exploration and development company. The company acquires, explores, operates, manages, and develops crude oil and natural gas assets. It holds interests and operates its oil and gas exploration projects such as Marlowe …
  • Yungjin Pharm Co Ltd (003520):企業の財務・戦略的SWOT分析
    Summary Yungjin Pharm Co Ltd (Yungjin), a subsidiary of KT&G Corp is a pharmaceutical company that develops, manufactures and distributes active pharmaceutical ingredients, formulations and tonic drinks. The company provides API products such as cephalosporins and other general products. It also off …
  • Vector Group Ltd (VGR):企業の財務・戦略的SWOT分析
    Vector Group Ltd (VGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Samuel Heath & Sons Plc:企業の戦略・SWOT・財務情報
    Samuel Heath & Sons Plc - Strategy, SWOT and Corporate Finance Report Summary Samuel Heath & Sons Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Endava Limited:企業の戦略・SWOT・財務情報
    Endava Limited - Strategy, SWOT and Corporate Finance Report Summary Endava Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆